<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-00689714</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-20T06:19:13+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Development of microemulsion of mitotane for improvement of oral bioavailability.</title>
            <author role="aut">
              <persName>
                <forename type="first">David</forename>
                <surname>Attivi</surname>
              </persName>
              <idno type="idhal" notation="numeric">766068</idno>
              <idno type="halauthorid" notation="string">630345-766068</idno>
              <idno type="IDREF">https://www.idref.fr/076892271</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Imane</forename>
                <surname>Ajana</surname>
              </persName>
              <idno type="halauthorid">630344-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Alain</forename>
                <surname>Astier</surname>
              </persName>
              <idno type="halauthorid">188493-0</idno>
              <affiliation ref="#struct-422739"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Béatrice</forename>
                <surname>Demoré</surname>
              </persName>
              <idno type="halauthorid">630346-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Stéphane</forename>
                <surname>Gibaud</surname>
              </persName>
              <email type="md5">bfd20e53264352ec086d609b328919cf</email>
              <email type="domain">univ-lorraine.fr</email>
              <idno type="idhal" notation="string">sgibaud</idno>
              <idno type="idhal" notation="numeric">4505</idno>
              <idno type="halauthorid" notation="string">3765-4505</idno>
              <idno type="IDREF">https://www.idref.fr/069329788</idno>
              <idno type="ORCID">https://orcid.org/0000-0003-3594-0601</idno>
              <idno type="VIAF">https://viaf.org/viaf/211096616</idno>
              <idno type="ISNI">http://isni.org/isni/0000000358835222</idno>
              <affiliation ref="#struct-422739"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Stéphane</forename>
                <surname>Gibaud</surname>
              </persName>
              <email type="md5">bfd20e53264352ec086d609b328919cf</email>
              <email type="domain">univ-lorraine.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2012-04-19 22:50:45</date>
              <date type="whenModified">2023-09-25 12:30:06</date>
              <date type="whenReleased">2012-04-19 22:50:45</date>
              <date type="whenProduced">2010-04</date>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="142148">
                <persName>
                  <forename>Stéphane</forename>
                  <surname>Gibaud</surname>
                </persName>
                <email type="md5">bfd20e53264352ec086d609b328919cf</email>
                <email type="domain">univ-lorraine.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-00689714</idno>
            <idno type="halUri">https://hal.science/hal-00689714</idno>
            <idno type="halBibtex">attivi:hal-00689714</idno>
            <idno type="halRefHtml">&lt;i&gt;Drug Development and Industrial Pharmacy&lt;/i&gt;, 2010, 36 (4), pp.421-7. &lt;a target="_blank" href="https://dx.doi.org/10.3109/03639040903225083"&gt;&amp;#x27E8;10.3109/03639040903225083&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Drug Development and Industrial Pharmacy, 2010, 36 (4), pp.421-7. &amp;#x27E8;10.3109/03639040903225083&amp;#x27E9;</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UNIV-LORRAINE">Université de Lorraine</idno>
            <idno type="stamp" n="CITHEFOR-UL">CITHEFOR Cibles thérapeutiques, formulation et expertise pré-clinique du médicament </idno>
            <idno type="stamp" n="BMS-UL">Pôle scientifique Biologie, Médecine, Santé de l'Université de Lorraine</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Development of microemulsion of mitotane for improvement of oral bioavailability.</title>
                <author role="aut">
                  <persName>
                    <forename type="first">David</forename>
                    <surname>Attivi</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">766068</idno>
                  <idno type="halauthorid" notation="string">630345-766068</idno>
                  <idno type="IDREF">https://www.idref.fr/076892271</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Imane</forename>
                    <surname>Ajana</surname>
                  </persName>
                  <idno type="halauthorid">630344-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Alain</forename>
                    <surname>Astier</surname>
                  </persName>
                  <idno type="halauthorid">188493-0</idno>
                  <affiliation ref="#struct-422739"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Béatrice</forename>
                    <surname>Demoré</surname>
                  </persName>
                  <idno type="halauthorid">630346-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Stéphane</forename>
                    <surname>Gibaud</surname>
                  </persName>
                  <email type="md5">bfd20e53264352ec086d609b328919cf</email>
                  <email type="domain">univ-lorraine.fr</email>
                  <idno type="idhal" notation="string">sgibaud</idno>
                  <idno type="idhal" notation="numeric">4505</idno>
                  <idno type="halauthorid" notation="string">3765-4505</idno>
                  <idno type="IDREF">https://www.idref.fr/069329788</idno>
                  <idno type="ORCID">https://orcid.org/0000-0003-3594-0601</idno>
                  <idno type="VIAF">https://viaf.org/viaf/211096616</idno>
                  <idno type="ISNI">http://isni.org/isni/0000000358835222</idno>
                  <affiliation ref="#struct-422739"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">12665</idno>
                <idno type="issn">0363-9045</idno>
                <idno type="eissn">1520-5762</idno>
                <title level="j">Drug Development and Industrial Pharmacy</title>
                <imprint>
                  <publisher>Taylor &amp; Francis</publisher>
                  <biblScope unit="volume">36</biblScope>
                  <biblScope unit="issue">4</biblScope>
                  <biblScope unit="pp">421-7</biblScope>
                  <date type="datePub">2010-04</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3109/03639040903225083</idno>
              <idno type="pubmed">19778161</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="mesh">Administration, Oral</classCode>
              <classCode scheme="mesh">Adrenocortical Carcinoma</classCode>
              <classCode scheme="mesh">Intestinal Absorption</classCode>
              <classCode scheme="mesh">Jejunum</classCode>
              <classCode scheme="mesh">Male</classCode>
              <classCode scheme="mesh">Mitotane</classCode>
              <classCode scheme="mesh">Particle Size</classCode>
              <classCode scheme="mesh">Rabbits</classCode>
              <classCode scheme="mesh">Rats</classCode>
              <classCode scheme="mesh">Rats, Wistar</classCode>
              <classCode scheme="mesh">Solubility</classCode>
              <classCode scheme="mesh">Surface-Active Agents</classCode>
              <classCode scheme="mesh">Animals</classCode>
              <classCode scheme="mesh">Antineoplastic Agents, Hormonal</classCode>
              <classCode scheme="mesh">Biological Availability</classCode>
              <classCode scheme="mesh">Drug Compounding</classCode>
              <classCode scheme="mesh">Drug Delivery Systems</classCode>
              <classCode scheme="mesh">Emulsions</classCode>
              <classCode scheme="mesh">Humans</classCode>
              <classCode scheme="halDomain" n="sdv.sp">Life Sciences [q-bio]/Pharmaceutical sciences</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>BACKGROUND: Mitotane (o,p'-DDD) is considered to be the drug of choice in the treatment of nonresectable and metastasized adrenocortical carcinoma. However, mitotane has poor solubility in the gastrointestinal tract and very low bioavailability. Consequently, to achieve therapeutic plasma level, high cumulative doses (4-6 g/day) of mitotane were usually used during 3-5 months. To shorten this equilibration time and reduce gastrointestinal side effects, a self-microemulsifying drug delivery system (SMEDDS) of mitotane has been developed. METHOD: First time, the solubility of mitotane was determined in various oils and surfactants; then, the influence of oils, surfactants, and cosurfactants on the formation of SMEDDS was investigated by constructing ternary phase diagrams. SMEDDS was characterized by morphological observations and droplet size measurements. Intestinal drug permeation of SMEDDS of mitotane (3 mM) was assessed in an Ussing-type apparatus and the bioavailability was determined in a rabbit model. RESULTS: The optimum formulation consisted of a mixture of Capryol, Tween, and Cremophor EL (33:33:33). The formulation was found to pass through the intestinal barrier much faster than a solution of mitotane (14.85 +/- 0.8 versus 3.03 +/- 0.2 micromol/cm(2)). Moreover, after oral administration in rabbits, the relative bioavailability was 3.4, compared with that of the conventional form (Lysodren). CONCLUSION: This SMEDDS can now be considered as a very good candidate to optimize the administration of mitotane.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="laboratory" xml:id="struct-422739" status="VALID">
          <idno type="IdRef">169566838</idno>
          <idno type="ISNI">0000000477690249</idno>
          <idno type="RNSR">200114728J</idno>
          <idno type="IdUnivLorraine">[UL]RNC--</idno>
          <idno type="ROR">https://ror.org/05adajg67</idno>
          <orgName>Cibles thérapeutiques, formulation et expertise pré-clinique du médicament</orgName>
          <orgName type="acronym">CITHEFOR</orgName>
          <date type="start">2012-01-01</date>
          <desc>
            <address>
              <addrLine>UL, Campus Brabois Santé, Bâtiment AB 1er étage, 9 avenue de la Forêt de Haye, BP 20199, 54505 Vandoeuvre Les Nancy Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://cithefor.univ-lorraine.fr/</ref>
          </desc>
          <listRelation>
            <relation name="UR3452" active="#struct-413289" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-413289" status="VALID">
          <idno type="IdRef">157040569</idno>
          <idno type="IdUnivLorraine">[UL]100--</idno>
          <idno type="ROR">https://ror.org/04vfs2w97</idno>
          <orgName>Université de Lorraine</orgName>
          <orgName type="acronym">UL</orgName>
          <date type="start">2012-01-01</date>
          <desc>
            <address>
              <addrLine>34 cours Léopold - CS 25233 - 54052 Nancy cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-lorraine.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>